| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF02353540 |
| P698 | PubMed publication ID | 7815310 |
| P2093 | author name string | J M Cardot | |
| G Y Lefèvre | |||
| J A Godbillon | |||
| P2860 | cites work | Pharmacokinetics of Hirudin | Q36917034 |
| The comeback of hirudin--an old-established anticoagulant agent | Q38192900 | ||
| Biology of recombinant hirudin (CGP 39393): a new prospect in the treatment of thrombosis | Q38735182 | ||
| A hirudin catching ELISA for quantitating the anticoagulant in biological fluids | Q41974875 | ||
| Pharmacological survey of recombinant hirudin | Q48101571 | ||
| Pharmacokinetics, effect on clotting tests and assessment of the immunogenic potential of hirudin after a single subcutaneous or intravenous bolus administration in man. | Q52423429 | ||
| Pharmacokinetics and pharmacodynamics of hirudin in man after single subcutaneous and intravenous bolus administration. | Q52426744 | ||
| Pharmacokinetics and anticoagulant effect of hirudin in man. | Q52431805 | ||
| Clinical pharmacology of recombinant hirudin | Q67976036 | ||
| Clinico-pharmacological studies with recombinant hirudin | Q68026562 | ||
| Effect of heparin, hirudin, and a synthetic thrombin inhibitor on antithrombin III in thrombin-induced disseminated intravascular coagulation in rats | Q68536268 | ||
| Pharmacological studies on the antithrombotic action of hirudin in experimental animals | Q70439861 | ||
| Clinical pharmacology of intravenously administered recombinant desulfatohirudin (CGP 39393) in healthy volunteers | Q71599934 | ||
| P433 | issue | 2 | |
| P921 | main subject | pharmacokinetics | Q323936 |
| hirudin | Q386715 | ||
| P304 | page(s) | 147-156 | |
| P577 | publication date | 1994-04-01 | |
| P1433 | published in | Journal of Pharmacokinetics and Pharmacodynamics | Q15766045 |
| P1476 | title | Pharmacokinetics of rec-hirudin in healthy volunteers after intravenous administration | |
| P478 | volume | 22 |
| Q73500562 | Characterization of C-terminal-truncated urinary metabolites of a recombinant hirudin in rats |
| Q34059396 | Desirudin: a review of its use in the management of thrombotic disorders |
| Q73562536 | Effect of renal impairment on the pharmacokinetics and pharmacodynamics of desirudin |
| Q44323022 | Effects of ximelagatran, an oral direct thrombin inhibitor, r-hirudin and enoxaparin on thrombin generation and platelet activation in healthy male subjects. |
| Q38410604 | Pharmacology and controlled release of hirudin for cardiovascular disorders |
Search more.